Jakarta – The Health Ministry has actually predicted the arrival of some 23.1 million doses of the COVID-19 vaccine produced by AstraZeneca in Indonesia in the first quarter (Q1) of 2021 under the COVAX Center plan.
The scheme is co-led by the Global Alliance for Vaccine and Immunization (GAVI), Coalition for Upsurge Preparedness Innovations (
GAVI in its letter, dated January 29, 2021, verified that the complimentary vaccine allocation to Indonesia for the initial phase would be between 13.7 million and 23.1 million doses made by AstraZeneca, Siti Nadia Tarmidzi, a spokesperson of the ministry’s COVID-19 vaccines, kept in mind in a statement here on Sunday.
The vaccines will be dispatched in 2 phases, consisting of 25-35 percent in the very first quarter of 2021 and 65-75 percent in the 2nd quarter of the preliminary stage of allowance.
The AstraZeneca vaccine can be administered to people aged 60 years and above.
Related news: COVID jab given to 482,145 medical employees: Health Ministry
” This is a success of our diplomacy. Through COVAX, we get access to complimentary vaccines and in quick time. It will certainly match the kinds of vaccines that currently exist. The AstraZeneca vaccine is one of the vaccines that can be administered to individuals aged 60 years and above. As we know, they are a group of individuals having the highest mortality rate,” she specified.
The Indonesian government had earlier signed the COVAX Facility vaccine form to finish the confirmation of involvement in the procurement of the totally free COVID-19 vaccines.
Indonesia has an opportunity to get a maximum of 108 million doses of vaccines from the international organization. The exact number of vaccine doses designated for Indonesia depends on the Indonesian diplomacy.
Foreign Affairs Minister Retno Marsudi has collaborated with Health Minister Budi Gunadi Sadikin to act on a number of areas that Indonesia should focus on in its preparations for the vaccine delivery.
Vaccines from COVAX will undoubtedly help with the government in satisfying the requirements of the COVID-19 vaccination program because the procurement of COVAX vaccines is totally free.
Indonesia has gotten commitments and options to get 663 million dosages of vaccines from AstraZeneca from the UK, Sinovac from China, Novavax from the United States and Canada, and Pfizer from the United States.
Related news: Indonesia strives for vaccine self-reliance in COVID battle
